Skip to main content
. Author manuscript; available in PMC: 2019 Jan 1.
Published in final edited form as: Am J Clin Oncol. 2018 Jan;41(1):24–29. doi: 10.1097/COC.0000000000000221

Table 1. Patient Population Description.

Characteristics No. of Patients (%) Characteristics No. of Patients (%)
Typical Carcinoid 47 (79.7)
Gender Tumor Size
 Male 18 (30.5)  <3 cm 32 (54.2)
 Female 29 (49.2)  >3 cm 10 (16.9)
Clinical Presentation  Unknown 5 (8.5)
 Asymptomatic 16 (27.2) Extent Resection
 Symptomatic 31 (52.5)  Lobectomyβ 44 (74.6)
Nodal Involvement  Pneumonectomy 1 (1.7)
 No 33 (55.9)  No Surgery 2 (3.4)
 Yes 2 (3.4) Treatment
 No Nodes Examinedα 11 (18.6)  None 2 (3.4)
 Unknown 1 (1.7)  Surg. Only 44 (74.6)
 Surg. & ChemoRTδ 1 (1.7)

Atypical Carcinoid 12 (20.3)
Gender Tumor Size
 Male 5 (8.5)  <3 cm 5 (8.5)
 Female 7 (11.9)  >3 cm 7 (11.9)
Clinical Presentation Extent Resection
 Asymptomatic 5 (8.5)  Lobectomyβ 10 (16.9)
 Symptomatic 7 (11.9)  No Surgery 2 (3.4)
Nodal Involvement Treatment
 No 2 (3.3)  Surg. Only 5 (8.5)
 Yes 9 (15.2)  Surg. & RTδ 1 (1.7)
 No Nodes Examinedα 1 (1.7)  Surg. & ChemoRTδ 4 (6.8)
 Chemo Only 1 (1.7)
 RT Onlyδ 1 (1.7)
α

No nodes were resected and submitted for pathologic review;

β

Lobectomy includes limited resections and bilobectomies;

δ

ChemoRT = chemotherapy and radiotherapy